{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:28:13Z","timestamp":1791300493585,"version":"4.1.0"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1097\/jcp.0000000000000094","type":"journal-article","created":{"date-parts":[[2014,2,21]],"date-time":"2014-02-21T10:29:50Z","timestamp":1392978590000},"page":"327-330","source":"Crossref","is-referenced-by-count":32,"title":["Hepatotoxicity Related to Agomelatine and Other New Antidepressants"],"prefix":"10.1097","volume":"34","author":[{"given":"Fran\u00e7ois","family":"Montastruc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Scotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines Ribeiro","family":"Vaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonor Nogueira","family":"Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Escudero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"S\u00e1inz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Falomir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haleh","family":"Bagheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Herdeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Venegoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Louis","family":"Montastruc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Carvajal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210128","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1001\/jama.287.17.2273","article-title":"Safety of newly approved drugs: implications for prescribing.","volume":"287","author":"Temple","year":"2002","journal-title":"JAMA"},{"key":"R2-9-20210128","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/hep.21095","article-title":"Drug-induced liver injury: summary of a single topic clinical research conference.","volume":"43","author":"Watkins","year":"2006","journal-title":"Hepatology"},{"key":"R3-9-20210128","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1056\/NEJMra052270","article-title":"Drug-related hepatotoxicity.","volume":"354","author":"Navarro","year":"2006","journal-title":"N Engl J Med"},{"key":"R4-9-20210128","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2165\/00002018-200730040-00001","article-title":"Drug-induced liver injury.","volume":"30","author":"Abboud","year":"2007","journal-title":"Drug Saf"},{"key":"R5-9-20210128","doi-asserted-by":"crossref","first-page":"947","DOI":"10.7326\/0003-4819-137-12-200212170-00007","article-title":"; U.S. Acute Liver Failure Study Group. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States.","volume":"137","author":"Ostapowicz","year":"2002","journal-title":"Ann Intern Med"},{"key":"R7-9-20210128","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1517\/14740338.2.3.249","article-title":"Antidepressant-induced hepatotoxicity.","volume":"2","author":"Lucena","year":"2003","journal-title":"Expert Opin Drug Saf"},{"key":"R8-9-20210128","first-page":"1187","article-title":"Nefazodone (Serzone) withdrawn because of hepatotoxicity.","volume":"169","author":"Choi","year":"2003","journal-title":"CMAJ"},{"key":"R9-9-20210128","first-page":"51","article-title":"Prescrire Int.","volume":"8","year":"1999","journal-title":""},{"key":"R10-9-20210128","doi-asserted-by":"crossref","first-page":"709","DOI":"10.2165\/11593960-000000000-00000","article-title":"A benefit-risk assessment of agomelatine in the treatment of major depression.","volume":"34","author":"Howland","year":"2011","journal-title":"Drug Saf"},{"key":"R12-9-20210128","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1046\/j.1365-2125.1997.00615.x","article-title":"Reports of hypoglycaemia associated with the use of ACE inhibitors and other drugs: a casenon-case study in the French pharmacovigilance system database.","volume":"44","author":"Moore","year":"1997","journal-title":"Br J Clin Pharmacol"},{"key":"R13-9-20210128","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2165\/00002018-199920020-00002","article-title":"The medical dictionary for regulatory activities (MedDRA).","volume":"20","author":"Brown","year":"1999","journal-title":"Drug Saf"},{"key":"R14-9-20210128","first-page":"3199","article-title":"Pharmacovigilance: a science or fielding emergencies Stat Med.","volume":"19","author":"Evans","year":"2000","journal-title":""},{"key":"R15-9-20210128","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/pds.1001","article-title":"The reporting odds ratio and its advantages over the proportional reporting ratio.","volume":"13","author":"Rothman","year":"2004","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R16-9-20210128","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4088\/JCP.v63n0208","article-title":"Hepatotoxicity associated with the new antidepressants.","volume":"63","author":"Carvajal Garcia-Pando A, Garcia del Pozo","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"R17-9-20210128","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1365-2125.2011.04037.x","article-title":"Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database.","volume":"72","author":"Montastruc","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"R18-9-20210128","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/pds.995","article-title":"Disproportionality analyses of spontaneous reports.","volume":"13","author":"Hennessy","year":"2004","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R19-9-20210128","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1136\/bmj.299.6697.519-a","article-title":"Hepatic injury caused by mianserin.","volume":"299","author":"Otani","year":"1989","journal-title":"BMJ"},{"key":"R20-9-20210128","first-page":"486","article-title":"Hepatotoxicity of mianserin: a case with positive reintroduction.","volume":"16","author":"Barbare","year":"1992","journal-title":"Gastroenterol Clin Biol"},{"key":"R21-9-20210128","first-page":"39","article-title":"Hepatic toxicity of mianserin.","volume":"6","author":"Urbain","year":"1985","journal-title":"Rev Med Brux"},{"key":"R22-9-20210128","first-page":"220","article-title":"Toxicite hepatique des nouveaux anti-depresseurs. A propos dune observation.","volume":"7","author":"Zarski","year":"1983","journal-title":"Gastroenterol Clin Biol"},{"key":"R23-9-20210128","doi-asserted-by":"crossref","first-page":"673","DOI":"10.5694\/j.1326-5377.1980.tb131972.x","article-title":"Mianserin: a possible cause of neutropenia and agranulocytosis.","volume":"2","year":"1980","journal-title":"Med J Aust"},{"key":"R24-9-20210128","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/0006-2952(90)90614-Q","article-title":"Formation of cytotoxic metabolites from phenytoin, imipramine, desipramine, amitriptyline and mianserin by mouse and human hepatic microsomes.","volume":"39","author":"Riley","year":"1990","journal-title":"Biochem Pharmacol"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JCP.0000000000000094","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:46:34Z","timestamp":1620956794000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-201406000-00009"}},"subtitle":["A Case\/Noncase Approach With Information From the Portuguese, French, Spanish, and Italian Pharmacovigilance Systems"],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0000000000000094","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]}}}